HOW TO TAKE THE POST-TEST: To obtain CME credit, please click here after reading the article to take the post-test on myCME.com. Neurogenic lower urinary tract dysfunction—or neurogenic bladder (NGB) ...

The underactive bladder syndrome market is expected to grow steadily, driven by an aging global population and rising prevalence of neurogenic and chronic conditions affecting bladder function.

One of the most helpful tests in the evaluation of neurogenic bladder is called a urodynamic test. Urodynamic testing is also called a cystometrogram (CMG). In this test a very small catheter is ...

First patient now successfully dosed in the EG110A clinical study being conducted at four leading US institutions Phase 1b/2a study to recruit 16 patients with neurogenic detrusor overactivity ...

Paris, Jan. 06, 2026 (GLOBE NEWSWIRE) -- 88% reduction in urinary incontinence episodes in patients with neurogenic bladder sustained through ...

The beta-3 adrenergic agonist mirabegron (Myrbetriq) gained an indication for neurogenic detrusor overactivity (NDO), a form of bladder dysfunction, in children 3 and older, the FDA announced Thursday ...

The US Food and Drug Administration (FDA) has expanded the indication for Mirabegron (Myrbetriq/Myrbetriq Granules) to treat neurogenic detrusor overactivity (NDO), a bladder dysfunction related to ...

Radiology tests like X-rays or ultrasounds are important parts of a neurogenic bladder diagnosis, but your doctor may order other tests as well. Neurogenic bladder is a condition that occurs when your ...

"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...

Barriers to care include patient embarrassment about their condition, lack of awareness that serious complications can result from mismanagement of incontinence, the perception that bladder issues are ...